Bone Biologics
BBLG • NASDAQ
Bone Biologics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey Frelick, with a market cap of $2.0M.
CEOJeffrey Frelick
Next Earnings
Upcoming earnings announcement for Bone Biologics
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.54
Earnings History
Past 12 earnings reports for Bone Biologics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$0.14Est: -$0.54 | +74.1% | - | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.37Est: -$1.23 | +69.9% | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$1.33Est: -$0.58 | -129.3% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.32Est: -$0.48 | +33.3% | - | — | 10-Q |
| Feb 28, 2025 | Q4 2024 | -$0.48Est: -$0.65 | +26.2% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$2.37Est: -$0.60 | -295.0% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.67Est: -$1.39 | +51.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$1.31Est: -$7.60 | +82.8% | - | — | 10-Q |
| Feb 21, 2024 | Q4 2023 | -$29.33Est: -$7.60 | -285.9% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$4.88Est: -$3.04 | -60.5% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$13.52Est: -$3.04 | -344.7% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$55.20Est: -$4.80 | -1050.0% | - | — | — |